Why dose matters
We cannot see, feel or smell radiation — but its effect is real. The X-ray doses used in medical imaging are usually low; so the main concern is not immediate harm but stochastic risk: a cancer risk whose probability is taken to rise with dose.1
For this relationship, radiation protection uses a linear no-threshold (LNT) model: at low doses, the probability of risk is assumed to rise with dose. The model is used not to compute individual risk precisely, but to prevent unnecessary dose and keep protection on the safe side. This is the basis of modern protection — keep dose as low as reasonably achievable (ALARA).1
A sense of scale
Rather than speak abstractly, let's look at real numbers. The average effective doses below are from Bushberg Table 11-8 (source: Mettler et al., Radiology 2008):12
| Exam | Average effective dose | Approx. background equivalent* |
|---|---|---|
| Hand/knee radiograph | 0.005–0.01 mSv | ~½–1 day |
| PA + lateral chest | 0.1 mSv | ~12 days |
| Mammography | 0.4 mSv | ~1.5 months |
| Abdomen radiograph | 0.7 mSv | ~2.5 months |
| Lumbar spine radiograph | 1.5 mSv | ~6 months |
| CT — Head | 2 mSv | ~8 months |
| CT — Chest | 7 mSv | ~2.3 years |
| CT — Abdomen | 8 mSv | ~2.6 years |
| CT — Three-phase liver | 15 mSv | ~5 years |
*A rough comparison computed against the US average natural background of 3.1 mSv/year (Bushberg p.399). These are average/representative values; actual patient dose varies with device, protocol, patient size, scan range, and country- or facility-specific practice.1
The core message is clear: a CT is not an X-ray. An abdominal CT is roughly equivalent to about 80 chest X-rays, or 2.6 years of natural background radiation. Though it may look like the same "imaging" task, the dose magnitude is entirely different — and that difference is exactly what makes tracking and optimization essential.
The rising medical burden
The data that best explains why dose tracking has grown from a personal matter into a societal one: per NCRP 160, the average US per-person effective dose from medical imaging rose from 0.53 mSv in 1987 to 3.0 mSv in 2006 — about a six-fold increase. Most of that rise comes from computed tomography (~50% of diagnostic exposure), with nuclear medicine adding ~25%.13
How big is the risk?
Risk stays vague without numbers. Per the BEIR VII report, the radiation-induced fatal cancer risk in a general population is taken as about 0.057 per 1,000 mSv (i.e. ~5.7%/Sv).14
Put in context: for an 8 mSv abdominal CT, this is roughly an added fatal cancer risk on the order of ~5 in 10,000. For an individual this is small, and in a justified exam the diagnostic benefit easily outweighs it. But when millions of exams are done each year, these small individual risks add up to a meaningful burden at the population level. This is precisely why dose tracking matters.
Why optimization is essential
Radiation protection rests on two core principles:5
- Justification: Is the exam truly needed? Does benefit outweigh risk? An unnecessary exam — however well optimized — is dose delivered for zero reason.
- Optimization (ALARA): If the exam is needed, it must use the lowest dose possible while preserving diagnostic quality. More dose does not always mean a better image; past a point it only adds risk.
Children are especially sensitive: both the radiogenic cancer risk is higher and organ doses can be higher than in adults. So optimizing pediatric protocols demands special care.1
The role of radiology physics
At the center of this whole equation is medical physics, and diagnostic radiology physics in particular — the discipline that makes dose visible, measures it, compares it and lowers it. The medical physicist's job:
- Protocol optimization: tuning parameters like kVp, mAs, pitch, filtration and reconstruction to cut dose without degrading diagnostic quality.
- Dose monitoring and DRLs: tracking exam doses, comparing them against diagnostic reference levels (DRLs), catching outlier protocols.
- Quality assurance (QA): ensuring equipment works accurately and consistently and does not deliver excess dose.
In short, dose does not optimize itself. Someone has to measure it, question it and improve it. That is exactly why DoseSave exists: to make dose visible and the dose–quality balance understandable for everyone.
References
- Bushberg JT, Seibert JA, Leidholdt EM, Boone JM. The Essential Physics of Medical Imaging, 3rd ed. Lippincott Williams & Wilkins, 2011. Bölüm 11 (Tablo 11-8, s.399–400), Bölüm 20 (s.751). Atıflardaki sayfa numaraları bu baskıya aittir.
- Mettler FA Jr, et al. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008;248:254–263. (Bushberg Tablo 11-8'in kaynağı.)
- NCRP Report No. 160. Ionizing Radiation Exposure of the Population of the United States. National Council on Radiation Protection and Measurements, 2009. (Kişi başı tıbbi doz artışı ve fon karşılaştırması — Bushberg s.399 üzerinden.)
- National Research Council. BEIR VII Phase 2: Health Risks from Exposure to Low Levels of Ionizing Radiation. 2006. (Stokastik risk katsayısı — Bushberg s.395 üzerinden.)
- ICRP Publication 103. The 2007 Recommendations of the International Commission on Radiological Protection. Ann. ICRP 37(2–4) — gerekçelendirme (justification) ve optimizasyon ilkeleri. icrp.org
- Paracelsus. Septem Defensiones (Üçüncü Defension), 1538: “Alle Dinge sind Gift, und nichts ist ohne Gift; allein die Dosis macht, dass ein Ding kein Gift ist.” — Latince özet: Sola dosis facit venenum (“yalnızca doz zehri yapar”).